|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0013216,
umls-concept:C0030705,
umls-concept:C0034380,
umls-concept:C0038952,
umls-concept:C0205179,
umls-concept:C0205390,
umls-concept:C0317760,
umls-concept:C0332161,
umls-concept:C0332287,
umls-concept:C0392760,
umls-concept:C0681205,
umls-concept:C0684249,
umls-concept:C1121484,
umls-concept:C1274040,
umls-concept:C1442989,
umls-concept:C1550555
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2004-5-20
|
|
pubmed:abstractText |
This open-label, randomised phase III study was designed to further investigate the clinical activity and safety of SRL172 (killed Mycobacterium vaccae suspension) with chemotherapy in the treatment of non-small-cell lung cancer (NSCLC).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0923-7534
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
15
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
906-14
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15151947-Adult,
pubmed-meshheading:15151947-Aged,
pubmed-meshheading:15151947-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:15151947-Bacterial Vaccines,
pubmed-meshheading:15151947-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:15151947-Cisplatin,
pubmed-meshheading:15151947-Female,
pubmed-meshheading:15151947-Humans,
pubmed-meshheading:15151947-Lung Neoplasms,
pubmed-meshheading:15151947-Male,
pubmed-meshheading:15151947-Middle Aged,
pubmed-meshheading:15151947-Mitomycins,
pubmed-meshheading:15151947-Quality of Life,
pubmed-meshheading:15151947-Survival Analysis,
pubmed-meshheading:15151947-Treatment Outcome,
pubmed-meshheading:15151947-Vinblastine
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
SRL172 (killed Mycobacterium vaccae) in addition to standard chemotherapy improves quality of life without affecting survival, in patients with advanced non-small-cell lung cancer: phase III results.
|
|
pubmed:affiliation |
The Royal Marsden Hospital NHS Trust, Sutton, Surrey, UK. maryo@icr.ac.uk
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase III
|
